-
1مراجعة
المؤلفون: Adami, Giovanni, Saag, Kenneth G., Chapurlat, Roland D., Guanabens, Nuria, Haugeberg, Glenn, Lems, Willem F., Matijevic, Radmila, Peel, Nicola, Poddubnyy, Denis, GEUSENS, Piet
المساهمون: Poddubnyy, Denis/0000-0002-4537-6015, Adami, Giovanni/0000-0002-8915-0755
مصطلحات موضوعية: benefit-risk ratio, biologics, denosumab, romosozumab
وصف الملف: application/pdf
العلاقة: THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 11 (Art N° UNSP 1759720X19883973); http://hdl.handle.net/1942/30356Test; 11; WOS:000492881100001
-
2
المؤلفون: Adami, Giovanni, Saag, Kenneth G., Chapurlat, Roland D., Guanabens, Nuria, Haugeberg, Glenn, Lems, Willem F., Matijevic, Radmila, Peel, Nicola, Poddubnyy, Denis, GEUSENS, Piet
المساهمون: Poddubnyy, Denis/0000-0002-4537-6015, Adami, Giovanni/0000-0002-8915-0755
مصطلحات موضوعية: benefit-risk ratio, biologics, denosumab, romosozumab
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od_______105::61cdd4e00d3fad818529b6f6e8ea4108Test
http://hdl.handle.net/1942/30356Test
النص الكامل